Tuberculosis and Respiratory Diseases

  • 제77권2호
  • /
  • Pages.60-64
  • /
  • 2014
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

Clinical Aspect of MicroRNA in Lung Cancer

  • Jeong, Hye Cheol (Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, CHA Bundang Medical Center, CHA University College of Medicine)
  • 투고 : 2014.06.20
  • 심사 : 2014.07.03
  • 발행 : 2014.08.29
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

MicroRNAs (miRNAs) are a class of small noncoding RNAs that modulate target gene activity, and are aberrantly expressed in most types of cancer as well in lung cancer. A miRNA can potentially target a diverse set of mRNAs; further, it plays a critical role in lung tumorigenesis as well as affects patient outcome. Previous studies focused mainly on abnormal miRNAs expressions in lung cancer tissues. Interestingly, circulating miRNAs were identified in human plasma and serum in 2008. Since then, considerable effort has been directed to the study of circulating miRNAs as one of the biomarkers of lung cancer. miRNAs expression of tissues and blood in lung cancer patients is being analyzed by more researchers. Recently, to overcome the high false-positivity of low-dose chest computed tomography scan, miRNAs in lung cancer screening are being investigated. This article summarizes the recent researches regarding clinical applications of miRNAs in the diagnosis and management of lung cancer.

키워드

참고문헌

  1. Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer 2013;52:356-69. https://doi.org/10.1002/gcc.22032
  2. Leal JA, Lleonart ME. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives. Cancer Lett 2013;338:174-83. https://doi.org/10.1016/j.canlet.2012.04.020
  3. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47. https://doi.org/10.1016/j.cell.2005.01.014
  4. Tufman A, Tian F, Huber RM. Can microRNAs improve the management of lung cancer patients? A clinician's perspective. Theranostics 2013;3:953-63. https://doi.org/10.7150/thno.6615
  5. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6. https://doi.org/10.1158/0008-5472.CAN-04-0637
  6. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57. https://doi.org/10.1016/j.ccr.2007.12.008
  7. Franchina T, Amodeo V, Bronte G, Savio G, Ricciardi GR, Picciotto M, et al. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J Cell Physiol 2014;229:97-9.
  8. Hu Z, Shu Y, Chen Y, Chen J, Dong J, Liu Y, et al. Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. Am J Respir Crit Care Med 2011;183:641-8. https://doi.org/10.1164/rccm.201005-0717OC
  9. Wang T, Lv M, Shen S, Zhou S, Wang P, Chen Y, et al. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS One 2012;7:e43268. https://doi.org/10.1371/journal.pone.0043268
  10. Voortman J, Goto A, Mendiboure J, Sohn JJ, Schetter AJ, Saito M, et al. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res 2010; 70:8288-98. https://doi.org/10.1158/0008-5472.CAN-10-1348
  11. Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, et al. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. Am J Respir Crit Care Med 2012;186:1160-7. https://doi.org/10.1164/rccm.201203-0534OC
  12. Barshack I, Lithwick-Yanai G, Afek A, Rosenblatt K, Tabibian-Keissar H, Zepeniuk M, et al. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol Res Pract 2010;206:578-84. https://doi.org/10.1016/j.prp.2010.03.005
  13. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 2009;106:12085-90. https://doi.org/10.1073/pnas.0905234106
  14. Abd-El-Fattah AA, Sadik NA, Shaker OG, Aboulftouh ML. Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. Cell Biochem Biophys 2013;67:875-84. https://doi.org/10.1007/s12013-013-9575-y
  15. Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011;11:374. https://doi.org/10.1186/1471-2407-11-374
  16. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L, et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 2011;3:495-503. https://doi.org/10.1002/emmm.201100154
  17. Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol 2014;32:768-73. https://doi.org/10.1200/JCO.2013.50.4357
  18. Shen J, Liao J, Guarnera MA, Fang H, Cai L, Stass SA, et al. Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis. J Thorac Oncol 2014;9: 33-40. https://doi.org/10.1097/JTO.0000000000000025

피인용 문헌

  1. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms vol.7, pp.1, 2014, https://doi.org/10.1186/s13045-014-0096-y
  2. Analysis of the miRNA-mRNA networks in malignant transformation BEAS-2B cells induced by alpha-particles vol.79, pp.9, 2016, https://doi.org/10.1080/15287394.2016.1176628
  3. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease vol.7, pp.14, 2014, https://doi.org/10.18632/oncotarget.7615
  4. Diagnostic MicroRNA Biomarker Discovery for Non-Small-Cell Lung Cancer Adenocarcinoma by Integrative Bioinformatics Analysis vol.2017, pp.None, 2017, https://doi.org/10.1155/2017/2563085
  5. Review of the Progress of miRNA-140 in the Study of Lung Cancer vol.8, pp.6, 2014, https://doi.org/10.12677/acm.2018.86086
  6. MicroRNAs in Vascular Eye Diseases vol.21, pp.2, 2020, https://doi.org/10.3390/ijms21020649